These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10087328)

  • 21. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo.
    Peng W; Zhao G; Ma Y; Yu H; Wang X
    Vaccine; 2011 Apr; 29(18):3501-6. PubMed ID: 21352943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
    Sas S; Chan T; Sami A; El-Gayed A; Xiang J
    Cancer Gene Ther; 2008 Oct; 15(10):655-66. PubMed ID: 18421311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice.
    Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y
    Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
    Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
    Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells.
    Henning P; Gustafsson T; Flach CF; Hua YJ; Strömbeck A; Holmgren J; Lindholm L; Yrlid U
    Eur J Immunol; 2011 Aug; 41(8):2185-96. PubMed ID: 21538977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
    Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys.
    Brown K; Gao W; Alber S; Trichel A; Murphey-Corb M; Watkins SC; Gambotto A; Barratt-Boyes SM
    J Immunol; 2003 Dec; 171(12):6875-82. PubMed ID: 14662894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
    Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
    Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
    Song W; Kong HL; Carpenter H; Torii H; Granstein R; Rafii S; Moore MA; Crystal RG
    J Exp Med; 1997 Oct; 186(8):1247-56. PubMed ID: 9334364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.
    Klein C; Bueler H; Mulligan RC
    J Exp Med; 2000 May; 191(10):1699-708. PubMed ID: 10811863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunization with dendritic cells infected with mTERT adenovirus vector effectively elicits immunity against mouse H22 hepatoma in vivo].
    Jiang N; Wang GS; Li H; Zhang J; Zhang JF; Yi SH; Yi HM; Yang Y; Cai CJ; Lu MQ; Chen GH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):405-9. PubMed ID: 19950546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses.
    Ochoa-Callejero L; Berraondo P; Crettaz J; Olagüe C; Vales A; Ruiz J; Prieto J; Tennant BC; Menne S; González-Aseguinolaza G
    J Med Virol; 2007 May; 79(5):522-9. PubMed ID: 17385694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.
    Kim JW; Kane JR; Panek WK; Young JS; Rashidi A; Yu D; Kanojia D; Hasan T; Miska J; Gómez-Lim MA; Ulasov IV; Balyasnikova IV; Ahmed AU; Wainwright DA; Lesniak MS
    Neurotherapeutics; 2018 Oct; 15(4):1127-1138. PubMed ID: 30027430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells.
    Ogawa F; Iinuma H; Okinaga K
    Scand J Immunol; 2004 May; 59(5):432-9. PubMed ID: 15140052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antitumor cytotoxic T lymphocyte response induced by dendritic cells transduced with DeltaNp73alpha recombinant adenovirus.
    Hu Y; He Y; Srivenugopal KS; Fan S; Jiang Y
    Oncol Rep; 2007 Nov; 18(5):1085-91. PubMed ID: 17914557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
    Kikuchi T; Miyazawa N; Moore MA; Crystal RG
    Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.